Concepedia

Andrew J. Yee

AJ

Statistics

Publications

85

Citations

5.5K

H-Index

39

Active since

1987

Affiliations

Massachusetts General Hospital(Current)

Harvard University

Dana-Farber Cancer Institute

Emory University

Johns Hopkins University

Andrew J. Yee is an author at Massachusetts General Hospital specializing in medicine, multiple myeloma, and multiple myeloma treatment.

ORCID

Publications per year

1987–2025

85

Publications

85

Oral Selinexor–Dexamethasone for Triple-Class Refractory Multiple Myeloma

Ajai Chari, Dan T. Vogl, Maria Gavriatopoulou et al. · New England Journal of Medicine · 2019 · 673 citations · Full text

, , +15

Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma

Paul G. Richardson, Susanna Jacobus, Edie Weller et al. · New England Journal of Medicine · 2022 · 463 citations · Full text

, , +14

Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial

Paul G. Richardson, Albert Oriol, Meral Beksaç et al. · The Lancet Oncology · 2019 · 385 citations · Full text

, , +11

Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial

María‐Victoria Mateos, Hilary Blacklock, Fredrik Schjesvold et al. · The Lancet Haematology · 2019 · 253 citations · Full text

, , +12

Frataxin activates mitochondrial energy conversion and oxidative phosphorylation

Michael Ristow, M. Pfister, Andrew J. Yee et al. · Proceedings of the National Academy of Sciences · 2000 · 222 citations

, , +17

1–5 of 85